Atara Biotherapeutics Inc. (ATRA) Financials Nov 2

Atara Biotherapeutics Inc. (ATRA) Financials Nov 20, 2014, 4:00 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Atara Biotherapeutics Inc.


Fiscal year is January-December. All values USD millions. 2012 2013 5-year trend
Sales/Revenue - - - - 0
Cost of Goods Sold (COGS) incl. D&A - - - - 4,000
COGS excluding D&A - - - - 0
Depreciation & Amortization Expense - - - - 4,000
Depreciation - - - - 4,000
Amortization of Intangibles - - - - 0
Gross Income - - - - (4,000)
2012 2013 5-year trend
SG&A Expense - - - - 8.61M
Research & Development - - - - 4.86M
Other SG&A - - - - 3.75M
Other Operating Expense - - - - 0
Unusual Expense - - - - 0
EBIT after Unusual Expense - - - - 0
Non Operating Income/Expense - - - - 0
Non-Operating Interest Income - - - - 12,000
Equity in Affiliates (Pretax) - - - - -
Interest Expense - - - - -
Gross Interest Expense - - - - -
Interest Capitalized - - - - -
Pretax Income - - - - (8.6M)
Income Tax - - - - 170,000
Income Tax - Current Domestic - - - - -
Income Tax - Current Foreign - - - - -
Income Tax - Deferred Domestic - - - - -
Income Tax - Deferred Foreign - - - - -
Income Tax Credits - - - - -
Equity in Affiliates - - - - -
Other After Tax Income (Expense) - - - - 0
Consolidated Net Income - - - - (8.77M)
Minority Interest Expense - - - - 0
Net Income - - - - (8.77M)
Extraordinaries & Discontinued Operations - - - - 0
Extra Items & Gain/Loss Sale Of Assets - - - - 0
Cumulative Effect - Accounting Chg - - - - 0
Discontinued Operations - - - - 0
Net Income After Extraordinaries - - - - (8.77M)
Preferred Dividends - - - - 0
Net Income Available to Common - - - - (8.77M)
EPS (Basic) - - - - (0.85)
Basic Shares Outstanding - - - - 13.68M
EPS (Diluted) - - - - (0.85)
Diluted Shares Outstanding - - - - 13.68M
EBITDA - - - - (8.61M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.